Growth Metrics

Dna X (SONM) Cash from Financing Activities (2018 - 2025)

Dna X's Cash from Financing Activities history spans 8 years, with the latest figure at $1.2 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at $1.2 million for Q4 2025, up 46.25% from a year ago — trailing twelve months through Dec 2025 was $19.5 million (up 319.41% YoY), and the annual figure for FY2025 was $19.5 million, up 319.41%.
  • Cash from Financing Activities for Q4 2025 was $1.2 million at Dna X, down from $7.2 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $18.6 million in Q4 2021 to a low of -$37000.0 in Q1 2023.
  • The 5-year median for Cash from Financing Activities is $591000.0 (2023), against an average of $3.3 million.
  • The sharpest move saw Cash from Financing Activities skyrocketed 676200.0% in 2022, then crashed 511.11% in 2023.
  • Year by year, Cash from Financing Activities stood at $18.6 million in 2021, then crashed by 100.19% to -$36000.0 in 2022, then decreased by 2.78% to -$37000.0 in 2023, then surged by 2262.16% to $800000.0 in 2024, then skyrocketed by 46.25% to $1.2 million in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $1.2 million, $7.2 million, and $4.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.